469 related articles for article (PubMed ID: 12907804)
21. Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice.
Ayers JI; Fromholt S; Sinyavskaya O; Siemienski Z; Rosario AM; Li A; Crosby KW; Cruz PE; DiNunno NM; Janus C; Ceballos-Diaz C; Borchelt DR; Golde TE; Chakrabarty P; Levites Y
Mol Ther; 2015 Jan; 23(1):53-62. PubMed ID: 25228069
[TBL] [Abstract][Full Text] [Related]
22. Axonal defects in mouse models of motoneuron disease.
Jablonka S; Wiese S; Sendtner M
J Neurobiol; 2004 Feb; 58(2):272-86. PubMed ID: 14704958
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral and adeno-associated vector-based therapy for motor neuron disease through RNAi.
Towne C; Aebischer P
Methods Mol Biol; 2009; 555():87-108. PubMed ID: 19495690
[TBL] [Abstract][Full Text] [Related]
24. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.
Lepore AC; Haenggeli C; Gasmi M; Bishop KM; Bartus RT; Maragakis NJ; Rothstein JD
Brain Res; 2007 Dec; 1185():256-65. PubMed ID: 17963733
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Setoguchi Y; Abe K
Apoptosis; 2002 Aug; 7(4):329-34. PubMed ID: 12101392
[TBL] [Abstract][Full Text] [Related]
26. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
[TBL] [Abstract][Full Text] [Related]
27. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
28. XIAP decreases caspase-12 cleavage and calpain activity in spinal cord of ALS transgenic mice.
Wootz H; Hansson I; Korhonen L; Lindholm D
Exp Cell Res; 2006 Jun; 312(10):1890-8. PubMed ID: 16566922
[TBL] [Abstract][Full Text] [Related]
29. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
Chi L; Ke Y; Luo C; Gozal D; Liu R
Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
[TBL] [Abstract][Full Text] [Related]
30. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
[TBL] [Abstract][Full Text] [Related]
31. Current developments in gene therapy for amyotrophic lateral sclerosis.
Scarrott JM; Herranz-Martín S; Alrafiah AR; Shaw PJ; Azzouz M
Expert Opin Biol Ther; 2015 Jul; 15(7):935-47. PubMed ID: 25959569
[TBL] [Abstract][Full Text] [Related]
32. Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS.
Zang DW; Lopes EC; Cheema SS
J Neurosci Res; 2005 Mar; 79(5):694-9. PubMed ID: 15668955
[TBL] [Abstract][Full Text] [Related]
33. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM
J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033
[TBL] [Abstract][Full Text] [Related]
34. Lack of changes in the PI3K/AKT survival pathway in the spinal cord motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
Peviani M; Cheroni C; Troglio F; Quarto M; Pelicci G; Bendotti C
Mol Cell Neurosci; 2007 Apr; 34(4):592-602. PubMed ID: 17303436
[TBL] [Abstract][Full Text] [Related]
35. Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS.
Wootz H; Hansson I; Korhonen L; Näpänkangas U; Lindholm D
Biochem Biophys Res Commun; 2004 Sep; 322(1):281-6. PubMed ID: 15313203
[TBL] [Abstract][Full Text] [Related]
36. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice.
Clement AM; Nguyen MD; Roberts EA; Garcia ML; Boillée S; Rule M; McMahon AP; Doucette W; Siwek D; Ferrante RJ; Brown RH; Julien JP; Goldstein LS; Cleveland DW
Science; 2003 Oct; 302(5642):113-7. PubMed ID: 14526083
[TBL] [Abstract][Full Text] [Related]
37. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy for ALS delivers.
Boillée S; Cleveland DW
Trends Neurosci; 2004 May; 27(5):235-8. PubMed ID: 15111001
[TBL] [Abstract][Full Text] [Related]
39. Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Abe K
Neurol Res; 2003 Mar; 25(2):195-200. PubMed ID: 12635522
[TBL] [Abstract][Full Text] [Related]
40. Metallothionein-III prevents neuronal death and prolongs life span in amyotrophic lateral sclerosis model mice.
Hashimoto K; Hayashi Y; Watabe K; Inuzuka T; Hozumi I
Neuroscience; 2011 Aug; 189():293-8. PubMed ID: 21640795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
